In patients with type 2 diabetes and kidney disease, Ozempic (semaglutide) reduced kidney disease progression, major adverse cardiovascular events (MACE)...
In patients with type 2 diabetes and kidney disease, Ozempic (semaglutide) reduced kidney disease progression, major adverse cardiovascular events (MACE)...